The frequency of cellular nodules as a new marker for metastase in colorectal cancer
Référence
85349-01
Mots-clés
Statut des brevets
European patent application EP02291166 filed on May 7th, 2002 and entitled « A novel biological cancer marker and methods for determining the cancerous or non-cancerous phenotype of cells »
Inventeurs
Gilles GADEA
Pierre ROUX
Statut commercial
Licensed
Laboratoire
Centre de Recherches de Biochimie Macromoléculaire (CRBM), a CNRS laboratory (UPR 1086), in Montpellier, France.
Description
TECHNICAL DESCRIPTION
The inventors have developed a method allowing the determination of the cancerous, metastatic cancerous or normal phenotype of cells, colorectal cells especially. This protocol is based on the unique property of metastatic colorectal cells to express long processes called filopodia that depend on the aggressiveness of cancer cells.
INDUSTRIAL APPLICATIONS
- Diagnostic and prognosis test for colorectal cancer
- Method for the screening of anti-metastatic compounds
- Method for the screening of the metastasic properties of a compound
For further information, please contact us (Ref 85349-01)
Besoin de plus d'informations ?
Nous contacterTechnologies Liées
-
24.02.2015
High Throughput Screening of LINGO Ligands: A New Drug Discovery Tool for the Treatment of Neurodegenerative Diseases
Outils de recherche et criblage 03247-01
-
20.02.2014
New cellular and animal toxic model of Parkinson’s disease
Outils de recherche et criblage 05155-01
-
04.10.2013
Method for screening anticancer substances, set or kit for implementing said method
Outils de recherche et criblage 86825-01